From: Analysis of 4 imaging features in patients with COVID-19
Patients (n=34) | |
---|---|
Area of lession | |
Unilateral lung | 11(32.4%) |
Bilateral lung | 23(67.6%) |
Number of lession | |
single lession | 10(29.4%) |
Multiple lessions | 24(70.6%) |
Lobe of lesion distribution | |
Multiple lobes | 19(55.9%) |
Two lobes | 4(11.8%) |
One lobe | 11(32.3%) |
Vascular thickening | |
Yes | 29(85.3%) |
None | 5(14.7%) |
Air bronchogram sign | |
Yes | 16(47.1%) |
None | 18(52.9%) |
GGO | |
Yes | 29(85.3%) |
None | 5 (14.7%) |
Pulmonary consolidation | |
Yes | 8(23.5%) |
None | 26(76.5%) |
Pulmonary fibrosis | |
Yes | 21(61.8%) |
None | 13(38.2%) |
Interlobular septal thickening | |
Yes | 29(85.3%) |
None | 5(14.7%) |
“feathery sign” | |
Yes | 22(65.2%) |
None | 12 (34.8%) |
“Dandelion sign” | |
Yes | 18(52.9%) |
None | 16(47.1%) |
“Pomegranate sign” | |
Yes | 9(26.1%) |
None | 25(73.9.%) |
“rime sign” | |
Yes | 7(20.6%) |
None | 27(79.4%) |
Solid nodule | |
Yes | 3(8.8%) |
None | 31(91.2%) |
Pleural effusion | |
Yes | 1(2.9%) |
None | 33(97.1%) |
Mediastinal Lymphadenopathy | |
Yes | 1(2.9%) |
None | 33(97.1%) |